Latest Epidermal growth factor receptor Stories
A protein which is intimately involved in cancer-promoting cell signaling also keeps a key component of the signaling pathway tied down and inactive.
New research shows that changing the shape of chemotherapy drug nanoparticles to make them rod-shaped rather than spherical can dramatically enhance their effectiveness at targeting and treating breast cancer.
For scientists to improve cancer treatments with targeted therapeutic drugs, they need to be able to see proteins prevalent in the cancer cells.
Cancer drugs of the new, molecular generation destroy malignant breast tumors in a targeted manner: They block characteristic molecules on tumor cells - receptors for the hormones estrogen or progesterone, or a co-receptor, called HER2, that binds to many growth factors.
Researchers from the Fox Chase Cancer Center recently discovered a novel method of improving cancer drugs, where they could block a specific pathway in the cell and provide an easier way for drugs to eliminate tumors.
A review in the December issue of the journal Archives of Pathology & Laboratory Medicine describes the current state of lung cancer care.
- A serpent whose bite was fabled to produce intense thirst.